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1. Introduction  
Staphylococcal enterotoxins (SEs) are exotoxins produced primarily by Staphylococcus aureus, 
which is a ubiquitous microorganism with world-wide distribution (Bergdoll, 1983; Dinges et 
al., 2000). SEs are a major cause of food poisoning and they are also potent immune activators 
that lead to serious immune dysfunction (Alouf and Muller-Alouf, 2003; McCormick et al., 
2001). Unlike most toxins, SEs are not directly cytotoxic and cell entry is not a requirement for 
them to cause an effect. The Centers for Disease Control and Prevention (CDC) place one SE, 
staphylococcal enterotoxin B (SEB), as a select agent based on its universal availability, ease of 
production and dissemination, and the potential to cause moderate but widespread illnesses. 
Additionally, because these agents are common to the environment and the diseases they 
cause are similar to other diseases, Category B agents require close environmental monitoring 
and enhanced disease surveillance (http://www.bt.cdc.gov/bioterrorism/).  
Many biothreat agents are common inhabitants of the soil and animals, and are known to 
cause disease in areas where they are indigenous. SEs present an additional problem in that 
SE-producing S. aureus are found throughout the world, and are known to produce a variety 
of illnesses, so that detection of a possible bioterrorist attack may be more problematic than 
those of other agents (Ahanotou, et al., 2006). The following sections describe SEB’s history 
as a biowarfare agent and its possible use as a bioterrorism agent. To understand why it is 
considered a Category B agent, a description of the toxin, the main diseases caused, methods 
to treat the diseases, and surveillance mechanisms will also be discussed.  
2. Biowarfare history 
In the era of offensive biological weapons, one of the SEs, SEB, was studied, not so much for 
its mass destruction capabilities but, rather for its ability to incapacitate soldiers so they 
would be incapable of fighting or defending their posts (Croddy and Hart, 2002; Hursh et 
al., 1995). The United States bioweapons program studied the toxin intensively and 
determined that the amount of SEB required to induce incapacitation was considerably less 
than that of synthesized chemicals. When the toxin and chemicals were compared by 
expense, time, and complexity of production, SEB was far more cost-effective. A dose of 400 
pg/kg body weights was estimated to incapacitate 50% of the human population exposed 
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by an aerosol attack, while 200 ng/kg body weights would be lethal for 50% of those 
exposed (Ahanotu, et al., 2006; Bellamy and Freedman, 2001; Ulrich et al., 1997).    
By 1966, the U.S. and its allies had produced stockpiles of various biowarfare (BW) agents, 
including SEB (under the code name WG) and research to establish parameters for SEB’s use 
as an aerosolized bioweapon continued at several facilities in the U.S. and Great Britain. In 
the fall of 1969, President Nixon stopped the offensive BW program and by 1972, all 
stockpiles of agents were destroyed (Greenfield et al., 2002; Franz et al., 1997). On April 10, 
1972, Great Britain, United States, and Soviet governments signed the Convention on the 
Prohibition of the Development, Production and Stockpiling of Bacteriological (Biological) 
and Toxin Weapons and on Their Destruction, which went into effect March 26, 1975.  
During the latter half of the Cold War, the Defense Intelligence Agency (DIA) and the 
Central Intelligence Agency (CIA) suspected that the USSR was continuing to stockpile and 
test biological weapons and therefore, defensive research programs were established for 
vaccine and therapeutic development (Ulrich et al., 1997). Not only have these research 
programs aided in development of surveillance mechanisms, the programs have 
significantly contributed to a greater understanding of diseases and the development of 
possible therapeutic interventions.  
With the end of the Cold War and dissolution of the USSR, threat of BW was greatly 
diminished. Other rogue nations were still stockpiling weapons and the CIA uncovered 
evidence that Iraq was building an arsenal of biological weapons. Although weaponized 
SEB was considered a high probability, it was not found when the Iraqi weapons program 
was dismantled (Zalinskas, 1997). 
3. The toxin 
SEB is one of several exotoxins isolated from S. aureus that are known for their emetic and 
superantigen traits (Bergdoll et al., 1974; McCormick et al. 2001). These exotoxins were the 
first superantigens to be identified, but since their discovery, additional superantigens have 
been isolated in other bacteria, particularly from the closely related genus, Streptococcus. 
Although staphylococcal and streptococcal superantigens are very similar, descriptions of 
toxin here will be limited to those toxins produced by staphylococci and the toxins will be 
identified as SEs or superantigens (SAG).  
3.1 Description of the toxin 
SEB belongs to a group of pyrogenic enterotoxins, produced primarily by S. aureus 
(McCormick et al., 2001). They are water soluble and relatively resistant to heat and 
proteolytic enzymes, including pepsin, trypsin, and papain (Le Loir et al., 2003). Stability 
does also depend upon purity of the toxin preparation, the medium’s composition, and the 
pH. SEB is one of the most stable toxins when exposed to extreme temperature and pH, one 
characteristic that makes SEB an attractive bioterrorism agent (da Cunha et al., 2007; Le Loir 
et al., 2003; Nout et al., 1988).  
Although they vary in amino acid sequence, SEs share a common three-dimensional 
structure that maintains their unique binding regions (Fig. 1) (Baker and Acharya, 2004; 
Papageorgiou et al., 1998). At least 20 serologically distinct SEs have been isolated primarily  
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Fig. 1. Molecular structure of SEB (from PDB:3SEB using Jmol version 12.0.41) showing ǂ- 
helices (magenta), ǃ-strands (gold), and loop strucuture. The ǃ-grasp domain is on the left, 
and the disulfide bond in the right. The N terminus and C terminus are labeled. 
from S. aureus (Table 1). Using the Clustal W program, the amino acid sequences of the SEs 
were aligned and evolutionary distances determined. A dendrogram constructed by the near 
neighbor-joining method divides the toxins into three major and two minor monophyletic 
groups (Ono et al., 2008; Uchiyama et al., 2003). The first two groups contain the classical 
toxins SEA, SED, SEE (Group 1) and SEB, SEC (Group 2) in addition to newly identified SEs; 
Group 3 contains only newly identified toxins. There is some similarity in structure in that 
Groups 1, 2, and 5 have a disulfide bond while Group 3 and Group 4 (TSST-1) do not.  
Many, but not all, SEs require zinc ions for functional binding to the MHC class II and for 
stability of its tertiary structure (Fraser et al., 1992; Ples et al., 2005); related to their amino 
acid sequences, the SEs bind zinc at various locations within the molecule (Brosnahan et al., 
2010). Some bind zinc in the concave ǃ sheet of the C terminal domain while others bind 
zinc in a cleft between the two domains. SEB and toxic shock syndrome toxin (TSST-1 do not 
bind zinc ions (Brosnahan and Shlievert, 2011; Ly, et al., 2001; Sundstrom, et al, 1996).  
3.2 Genetic analysis of SE genes 
Analysis of SE genes indicates divergence from a common ancestry. Most genes coding for 
the enterotoxins are found on mobile elements such as pathogenicity islands, plasmids and 
bacteriophages, making horizontal transfer a common occurrence (Jarraud et al., 2001; 
McCormick et al, 2001; Yarwood, et al., 2002). In 2001, a cluster of genes with homologies to 
SE genes was identified and named the enterotoxin gene cluster (egc). Since many of the 
genes produced SE-like proteins, Jarraud et al. (2001) suggested that the gene cluster formed 
an enterotoxin nursery where genomic rearrangements would lead to new SEs, a fact that 
has now been confirmed with the development of the new exotoxin SEG (Lindsay, 2011; 
Thomas et al., 2006).  
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SEA 27.1 phage yes
SED 26.9 plasmid (pIB485) yes
SEE 29.6 prophage yes
SEJ 31.2 plasmid (pIB485) yes
SEN 26.1 egc
c
yes
SEO 26.8 egc yes
SES 26.2 phage yes
SEP 26 phage yes
SHE
c
25.1 transposon yes
SEB 28.4 SaPI
d
yes
SEC1 27.5 SaPI yes
SEC2 27.6 SaPI yes
SEC3 27.6 SaPI yes
SEG 27 egc yes
SEIR 27 plasmid (pIB485) yes
SEU 27.2 egc yes
3 SEI 24.9 egc poor
SEK 26 SaPI yes
SEL 26.8 SaPI no
SEM 24.8 egc yes
SEQ 26 SaPI unknown
4 TSST-1 21.9 PI no
5 SET 22.6 egc poor 
MW (kDa) Gene Locationb Emetic 
1
2
Groupa Enerotoxin
a  
aStaphilococcal enterotoxins are divided into 5 monophyletic groups according to ammino acid 
sequence alignment (Uchiyama et al., 2003; Ono et al., 2008) 
bGene location of the toxin 
centerotoxin gene cluster 
dStaphylococcus aureus phatogeniciti islands 
Table 1. Staphylococcal enterotoxin/superantigens 
As shown in Table 1, genetic elements containing SE genes vary. Most are located on mobile 
genetic elements (MGEs) which are DNA pieces with ends that encode genes (Lindsay, 
2011). There are several types of MGEs, including plasmids, pathogenicity islands, 
bacteriophages, and transposons. MGEs move from one bacterium to another or between 
various genetic elements in the same bacterium. Mobility of the genes is thought to 
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contribute to the number and genetic variation within this group of toxins. Interestingly, 
however, diversity in amino acid sequences has not affected toxin binding to its receptors, 
suggesting that as the proteins evolved, selective pressures maintained their binding sites by 
keeping a tertiary structure that supports the characteristic binding (Baker and Achara, 2004; 
Ulrich et al., 2007). 
Expression of SE genes is highly regulated by growth phase and environmental conditions, 
and not all conditions are suitable for gene activation (Lindsay, 2011). With the proper 
medium, most toxin production occurs in late log or stationary phase (Otero et al., 1990; 
Rahkovic et al., 2006; Soejima et al, 2007). S. aureus produces regulatory proteins and small 
RNAs that control toxin production, probably so that in harsh conditions, the bacterium can 
conserve energy (Horsburg, 2008; Fournier, 2008).  
One major regulator of some, but not all SE toxin production, is the accessory regulator gene 
(Agr) system (Lindsay, 2011). When bacteria reach a critical mass, a quorum-sensing system 
activates Agr, which, in turn, activates some toxin genes (SEB, for example). Other 
regulatory systems such as SarA can also up-regulate toxin genes indicating that regulatory 
pathways are complex and multiple systems probably control toxin production. 
3.3 Superantigen characteristics of SEB 
Marrack and Kappler (1990) coined the term “superantigen” to connote the similarities 
between SEs and conventional protein antigens that activate T cells by cross-linking T cells 
to antigen-presenting cells (APC). Both superantigens (SAG) and conventional antigens bind 
to the major histocompatibility class II (MHC class II) receptor located on APCs (Haffner, et 
al., 1996). However, conventional antigens bind to MHC class II molecules inside their 
antigen-binding grove and are processed into peptides expressed on the cell surface before 
they are presented to T cells via the T-cell receptor (TCR). In contrast, SAGs bind directly to 
MHC class II molecules outside the antigen-binding groove; they are not processed into 
peptide fragments before presentation to TCRs (Fig. 2). 
 
Fig. 2. Conventional antigen and SAGs bind APC and TCR. (A) SAGS bind to the outer 
region of the TCR Vβ and to the outer region of the MHC Class II determinant. (B) 
Conventional antigens are processed into peptides that are then presented to the antigen-
binding region of the TCR. 
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While SAG must first bind to MHC class II molecules, their ability to activate large 
populations of T cells depends largely upon their binding to the TCR (Alber et al., 1990; 
Pontzer, et al., 199; Stevens, 1997; White et al., 1989). There are five different elements (Vǂ, 
Jǂ, Vǃ, Dǃ, and Jǃ) that comprise the two-chain TCR receptor with each composed of a 
constant and variable region. The TCR uses all five elements for recognition of processed 
peptides on the surface of APCs (from conventional antigens). Peptide binding occurs 
within the peptide-binding region and requires a helper molecule such as CD4. 
Superantigens bind only to Vǃ elements and specificity of binding results from the types of 
Vǃ molecules present (Fig. 1). For example, SEB binds to human Vǃ phenotypes 3, 12, 14, 15, 
17, which differ from phenotypes bound by other SAGs (Table 2). Because many T cells 
contain the same Vǃ phenotype, SAGs may activate up to 20% of the whole T-cell 
population rather than the 0.01% activation by conventional antigens.  
SAGs are not restricted and can bind to both CD4 and CD8 T cells if the SAG recognizes the 
TCR Vǃ chains, which increases the number of T cells they can affect. Superantigen-
activated T cells can undergo at least five to six rounds of cell division (Nagshima et al., 
2004). The massive clonal T-cell expansion results in the activation of programmed cell 
death in which cells responding to the specific superantigen are deleted (Choi et al., 1989; 
Yuh et al., 1993). Apoptosis of large numbers of T cells, clonal deletion and anergy of 
specific T-cell populations, and massive release of proinflammatory cytokines are all factors 
in the toxin’s pathogenesis. 
4. SE pathogenesis 
There are two major diseases caused by the staphylococcal enterotoxin superantigens (SEs), 
and most diseases attributed to the SEs relate to chronic disease states caused by 
autoimmunity and repetitious stimulation by SEs. Those autoimmune diseases in which SEs 
are thought to play a role require more than one challenge and therefore, will probably not 
be a concern in a bioterrorism threat. The two diseases that are pertinent to potential 
bioterrorism attacks are SEB (or SEs) in the food or water supply (food poisoning) or an 
aerosol attack in which the toxin will be inhaled into the lungs, possibly causing toxic shock 
syndrome.  
4.1 Food poisoning 
As noted previously, S. aureus is a ubiquitous microorganism with a world-wide 
distribution, and is responsible for causing large numbers of food poisoning cases 
throughout the world (Bergdoll, 1989; Le Loir et al., 2003; Ortega, et al., 2010). In its normal 
environment, the gram-positive cocci and its toxins do not cause disease; however, when 
introduced into foods such as cream, mayonnaise, or similar foods, the bacteria grow 
rapidly secreting the exotoxins which then contaminate the food. Dack and coworkers (1930) 
provided the first documented report that identified a toxin from S. aureus as a causative 
agent of a food poisoning incident involving staphylococci-contaminated Christmas cake. 
The investigators grew the bacteria isolated from the cake and found that a sterile filtrate 
from the broth in which the bacteria were grown induced food poisoning when ingested by 
human volunteers. Thereafter, from investigations of various food poisoning outbreaks, an 
initial five antigenically distinct enterotoxins were identified suggesting that S aureus 
produced a family of protein toxins possessing similar properties and virulence (Casman, 
www.intechopen.com
 
Staphylococcal Enterotoxins, Stayphylococcal Enterotoxin B and Bioterrorism 
 
47 
1960; Bergdoll et al., 1959; Bergdoll et al., 1965; Casman et al., 1967). Since the 
characterization of the five serotypes, at least 20 more SEs (Table 1) have been isolated and 
characterized with many inducing emesis in monkeys or humans (Uchiyama et al., 2003).  
Enerotoxin TCR Vβ Specificity 
SEA 1.1,5.3,6.3,6.4,6.9, 
  7.3,7.4,9.1,18 
SEB 3,12,14,15,17,20
SEC1 3,6.4,6.9,12,13.2,14,15,17,20 
SEC2 12,13.2,14,15,17,20 
SEC3 3,5,12,13.1,13.2
SED 5,12 
SEE 5.1,6.3,6.4,6,9,8.1,18
SEG 13.6,14,15 
SHE Vα10
SEI 1,5.1,5.2,5.3,23 
SEJ ND
SEK 5.1,5.2,6.7 
SEL 5.1,5.2,6.7,16,22
SEM 18,21.3 
SEN 9
SEO 5.1,7,22 
SEIP 5.1,6,8,16,18,21.3
SEQ 2,5.1,5.2,6.7,21.3 
SEIR 3,11,12,13.2,14
SEU 13.2,14 
TSST-1 2,4  
Table 2. Staphylococcal enterotoxins showing the corresponding TCR V repertoires 
Approximately 25% of healthy people and animals carry S. aureus on the skin and often food 
workers who carry the bacterium may contaminate food when they handle food without 
washing their hands or wearing gloves. The microorganism is also found in unpasteurized 
milk and cheese products and, being salt tolerant, grows in salty foods as well. Because they 
are highly resistant to heat and enzymatic inactivation, foods that do not require cooking or 
those prepared by hand provide greater risks of contamination with the bacteria and 
subsequent toxin production. The short incubation period, approximately 4-6 hr after 
ingestion, usually differentiates SE-induced food poisoning from those caused by bacteria 
such as E. coli or Salmonella species where presence of the bacteria is required for disease. 
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The onset is sudden and vomiting is the hallmark symptom. Other symptoms, such as 
diarrhea, abdominal pain, and nausea may also be present, but systemic manifestations such 
as fever are very uncommon (Alouf and Muller-Alouf, 2003; Kerouanton et al., 2007). 
Although extremely incapacitating, staphylococcal food poisoning is usually self-limiting 
and symptoms last about 1 day. Fatality in healthy adults is rare (0.03%); however, the rate 
is higher in susceptible populations (children, elderly, and immune-compromised adults) 
and may also depend upon the concentration of the toxin ingested (Do Carmo, et al., 2004). 
SE-induced food poisoning was initially thought to be caused by the local interaction of the 
toxin with intestinal cells because the toxin stimulates nerve centers in the gut through 
serotonin (5-hydroxytryptamine or 5 HT) release from intestinal mast cells (Alouf and Muller-
Alouf, 2003; Hu et al., 2007). Serotonin binds to 5-HT3 receptors which are ligand-gated ion 
channels located on the afferent vagus nerve terminals. The binding of serotonin to the 
receptor opens the channel which signals the medulla emetic reflex center to generate nausea 
and an emetic response. However, such interactions do not explain the disease 
pathophysiology. Patients with SE intoxication can exhibit rather severe gastrointestinal 
damage including mucosal hyperemia, regional edema, petechiae, and purulent exudates 
(Ortega et al., 2010; Palmer, 1951). SEs cross the intestinal epithelial barrier and gain access to 
local and systemic lymphoid tissues, suggesting that activation of local immune tissue may be 
partially responsible for gastrointestinal damage (Hamad et al., 1997). Involvement of the 
immune system in pathogenesis could explain why immuno-compromised adults develop a 
more severe, life-threatening disease than normal healthy adults. However, emesis is not 
directly linked to T-cell proliferation because TSST-1, a potent immune activator, does not 
cause emesis. TSST-1 is more susceptible to enzymes in the digestive tract and could be the 
reason for its lack of emetic activity. SEs with emetic activity have a disulfide bond located at 
the top of the B domain and probably are responsible for stabilizing the molecule in a 
conformation needed to induce emesis (Brosnahan and Schievert, 20l1).  
4.2 Toxic shock syndrome 
During the late 1970’s, Todd and coworkers (1978) described an acute illness in seven 
children, between the ages of 8 to 17. Symptoms included high fever, hypotension, 
vomiting, watery diarrhea, a scarlatiniform rash, and renal failure. Although bacteria were 
not isolated from blood, cerebrospinal fluid, or urine, S. aureus was isolated from mucosal 
sites. Culture filtrates from cultures of these isolates were shown to contain a toxin that 
would cause a rash (Nikolksy sign) in newborn mice. Todd named the new disease toxic 
shock syndrome (TSS). In 1977 through 1980, 22 women between the ages of 13-24, were 
diagnosed with TSS (Chesney et al., 1981). Investigations showed that this TSS was the 
result of highly absorbent tampons, which became contaminated with S. aureus. A toxin, 
tsst-1, was isolated from the bacteria cultured from the contaminated tampon and shown to 
be similar to that discovered by Todd et al. (1978). The super absorbent tampons were found 
to introduce oxygen into the anaerobic environment of the vagina which facilitated the 
growth of S. aureus and release of TSST-1. When the absorbent tampons were taken off the 
market, the incidence of menstrual TSS decreased dramatically.  
From these early investigations, TSS has been divided into two categories. The first, 
menstrual TSS, occurs primarily in young women, ages 16-25, during menstrual periods and 
is usually associated with tampon use. As first identified in the 1980s, TSST-1, remains the 
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leading cause of menstrual TSS (Chesney et al, 1981; Brosnanhan and Schlievert, 2010). 
TSST-1 is also a major etiologic agent for the other TSS category, non-menstrual TSS, 
comprising 50% of the reported cases (Buchdahl et al, 1985). Two other SEs, SEB and SEC, 
have been identified as the causative agent in most of the remaining 50%. Since its 
discovery, TSS had been considered a rare, but often fatal disease. After removal of 
absorbent tampons from the market and efforts to inform the public about TSS, incidences 
of menstrual TSS dropped from 13.7% to 0.3% per 100,000 individuals in the U. S. Since 
1986, reported incidences of TSS in the U.S. have remained stable with the annual incidence 
rate around 0.32%-0.52% per 100,000 people (DeVries, et al., 2011; Haijeh et al., 1996). 
Several reasons may account for the disease’s rarity. One reason lies in the fact that most 
adults have been exposed to SEs over a period of many years, and therefore, possesses 
antibodies against many of the SEs. The lack of anti-SE antibodies could also explain why 
children and young adults are more susceptible to the disease. In addition to immunity 
against SEs, another problem in TSS diagnosis relates to the lack of a single diagnostic test 
and, therefore, diagnosis relies upon a complex analysis of clinical symptoms. Requirements 
for a case to be identified as TSS are rigorous, and while SEs are significant virulence factors 
in many infections, most infections do not meet the diagnostic criteria for TSS as established 
by CDC (Table 3).  
TSS pathophysiology involves many intricate extracellular and intracellular signaling 
pathways and at this time, the exact pathways or pathways responsible for the syndrome 
are not known (Davis et al., 1980; Kumar et al., 2010; Pinchuk et al., 2010). Hallmark studies 
during the 1990s showed that the toxicity of SEB was due to massive T-cell proliferation and 
proinflammatory cytokine production (Marrack et al., 1990; White et al., 1989). 
Investigations using T-cell reconstituted immuno-deficient SCID mice confirmed the role of 
T-cell activation in SE-induced lethality (Miethke et al., 1992; Canaan, et al. 1999). 
Furthermore, these studies indicated that tumor necrosis factor alpha (TNF-ǂ) plays a 
crucial role in SE-induced lethality because passive immunization with an anti-TNF-ǂ/ǃ 
monoclonal antibody protected the animals against an SE challenge (Fast et al., 1989; 
Miethke et al., 1992). Although the precise mechanisms by which proinflammatory 
cytokines induce TSS, these early studies and further investigations provide overwhelming 
evidence that tissue damage, shock, and multiple organ failure is caused by the production 
of pathological concentrations of proinflammatory cytokines and chemokines such as TNF-
ǂ, interleukin 1ǃ (IL-1 ǃ), interferon gamma (IFN-Ǆ) and interleukin 6 (IL-6), and 
macrophage chemoattractant protein-1 (MCP-1) (Marrack et al., 1990; Williams, 1991). 
Although T cells appear to play a dominant role in TSS, more recent investigations indicate 
that SE interactions with other cell types may also contribute to TSS pathophysiology (Das, 
2000; Faulkner et al., 1997; Marrack et al., 1990; McCormick et al. 2001). Initially, the purpose of 
the APC MHC class II interaction with SEs was thought to provide a mechanism for T-cell 
activation and production of proinflammatory cytokines by T-cell populations. That MHC 
class II interactions play a more active role in TSS was shown by studies in which mortality 
from TSST-1 was not reduced in T-cell depleted rabbits (Dinges et al, 2003). In addition, TSST-1 
induced proinflammatory cytokines in these animals, again suggesting that other cells may 
play a role in cytokine production. These studies are further supported by investigations in 
which the SE-MHC class II interaction by itself was shown to be sufficient to activate 
intracellular signaling pathways which induce downstream pro-inflammatory signaling and 
subsequent production of cytokines (Kisner (a) et al., 2011; Kisner (b) et al., 2011).  
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 Fever: temperature greater than or equal to 38.9°C 
Rash: diffuse macular erythroderma 
Desquamation: 1-2 weeks after onset of rash 
Hypotension: systolic blood pressure less than or equal to 90 mm Hg 
for adults or less than fifth percentile by age for children aged less than 16 years 
Multisystem involvement (three or more of the following organ systems: 
Gastrointestinal: vomiting or diarrhea at onset of illness  
Muscular: severe myalgia or creatine phosphokinase level 
at least twice the upper limit of normal 
Mucous membrane: vaginal, oropharyngeal, or conjunctival hyperemia 
Renal: blood urea nitrogen or creatinine at least twice the upper limit of 
normal for laboratory or tract infection 
Urinary sediment with pyuria (greater than or equal to 5 leukocytes 
per high-power field) in the absence of urinary tract infections
Hepatic: total bilirubin, alanine aminotransferase enzyme, or asparate 
aminotransferase enzyme levels at least twice the upper limit of normal values
Hematologic: platelets less than 100,000/mm3 
Central nervous system: disorientation or alterations in consciousness 
without focal neurologic signs when fever and hypotension are absent 
Laboratory criteria for diagnosis
Negative results on the following tests, if obtained: 
Blood or cerebrospinal fluid cultures blood culture may be positive for 
Staphylococcus aureus 
Negative serologies for Rocky Mountain spotted fever, leptospirosis, 
or measles 
Case classification
Probable: a case which meets the laboratory criteria and in which four of the 
five clinical findings described above are present 
Confirmed: a case which meets the laboratory criteria and in which all five of 
the clinical findings described above are present, including desquamation, 
unless the patient dies before desquamation occurs  
CSTE Position Statement Number: 10-ID-14 
Clinical case definition
 
 
Table 3. CDC 1997 Definition for Toxic Shock Syndrome 
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Fig. 3. Systemic SEB (SE) intoxication is a complex disease 
SEB interacts with (A) lymphoid cells and induces production of proinflammatory 
cytokines. SEB stimulates (B) endothelial and (C) epithelial cells to release cytokines (some 
proinflammatory)/chemokines and growth factors. Red arrows show interactions between 
cell types are also affected by SEB-induced release of these factors that ultimately leads to 
endothelial cell dysfunction, vascular leak, and shock resulting from multi-organ failure.  
SE binding to lymphoid cells has been extensively characterized and interactions of SEs with 
these cells are fairly well understood (Achara and Baker, 2004; Broshanan et al. 2011; Larkin 
et al., 2009). The complexity of the disease suggests that SEs may affect more than lymphoid 
cells, and recently, an epithelial binding moiety has been identified on the SE molecule 
(Brosnahan and Schlievert, 20011). SEs bind to epithelial cells and elicit the production of 
specific cytokines. SEs have also been shown to cross polarized epithelial cells in vitro 
suggesting that SEs gain systemic access to the body (Hale, unpublished data). Rajagpjalan 
et al. (2007) show acute activation of the systemic immune system and inflammatory 
response in mice that were vaginally or intranasally exposed to SEB (Rajagopalan et al. 2007; 
Rajagopalan et al., 2006). Since the toxin was introduced on mucosal surfaces, the only 
method for systemic activation would be if the toxin crossed the epithelial cell barrier and 
gained access to the body. Vaginal epithelial cells were also shown to bind TSST-1 and 
induce TNFǂ production while treatment of epithelial cells with TSST-1 or SEB induced 
production of MIP-3ǂ and IL-8 (Brosnahan et al., 2001; Peterson, et al., 2005).  
SE-induced shock causes severe damage to the endothelial vasculature and vascular leak 
contributes significantly to TSS pathology (Krakauer, 1994; Ortega et al. 2010). Elevated 
levels of vascular endothelial growth factor are observed in serum from patients with sepsis 
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or septic shock (Karlsson et al. 2008). Because there are common features among 
hemorrhagic shock, septic shock, and toxic shock syndrome, factors that regulate 
endothelial homeostasis are probably important in its prevention. Future studies examining 
the interplay among lymphoid, endothelial and epithelial cells will provide more 
understanding of the disease and enable a logical approach for therapy.  
4.3 Pulmonary complications 
One of the most effective and deadly forms of a bioterrorism attack is delivery of the toxin 
or microorganism by aerosol exposure (Ulrich et al., 1997). Understanding SE-intoxication in 
humans has been difficult because there is no direct comparison between the pathogenesis 
of human disease and the disease caused by an intentional aerosol attack. Perhaps the most 
descriptive and informative reports detailed an accidental laboratory inhalational exposure 
of fifteen workers (Rusnak et al., 2004). Ten became symptomatic and nine were 
hospitalized. The onset was rapid (1 1/2 hrs to 24 hr) after exposure with the illness lasting 
3-4 days. Commonly observed symptoms were fever, headache, myalgias, pulmonary 
symptoms, and gastrointestinal symptoms.   
A Rhesus macaque animal model was used to characterize SEB intoxication by an aerosol 
route. In these studies, nonhuman primates (NHP) were exposed to a lethal dose (5 LD50) of 
aerosolized SEB in a modified Henderson head-only aerosol exposure chamber. NHPs 
developed gastrointestinal symptoms (anorexia, diarrhea, and emesis) within 24 hr after 
exposure. The gastrointestinal symptoms appeared to be self-limiting, but 24 hr later, the 
NHPs developed an abrupt onset of lethargy, dyspnea, and facial pallor. Usually within 4 
hr, the animals died or were euthanized when moribund. Postmortem examination revealed 
lesions in the lungs and signs of pulmonary edema. Both large and small intestines showed 
petechial hemorrhaging and mucosal erosion, and lymph nodes were swollen. There was 
definite damage to the endothelium and endothelial cells. The authors of the study 
concluded that SEB is a potent stimulant in rhesus monkeys and that a similar dose in 
humans could produce similar symptoms. One thing to consider, however, when 
extrapolating from NHP to human, is that the NHP were seronegative when tested for the 
presence of antibodies against SEB; most humans have some degree of past exposure to the 
toxin and therefore would perhaps have some immunity.  
Since these studies on NHP, there is evidence that links SEs exposure to asthma and 
respiratory problems (Kumar et al., 2010). Inflammatory reactions in the lung are induced 
by TNF-ǂ and two life-threatening syndromes, vascular leak and respiratory distress 
develop during toxic shock (Aubert et al., 2000; Herz et al., 1999; Neuman et al., 1997). Other 
studies show that cytokine-mediated acute respiratory distress syndrome and inflammatory 
lung disease occur during SE intoxication (DeSouza et al., 2006; Fujisawa et al., 1998; Slifka 
and Whitton, 2002). Both conditions are critical and may be lethal without therapeutic 
intervention (Das, 2000; Kasai et al., 1997). Anti-inflammatory drugs reduce TNF-ǂ and 
other proinflammatory cytokines which alleviates the symptoms and helps the individuals 
to recover from these life-threatening illnesses. 
5. Animal models  
A major problem in understanding the disease process of SE intoxication is the lack of 
appropriate animal models that mimic the human disease. There are several animal models 
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for studying TSS, but each model has its own limitations, which need to be understood in 
order to use each model in furthering our understanding of the disease process.  
5.1 Mouse 
The mouse remains the most common model for TSS studies, although they are not sensitive 
to the toxin and must be sensitized with either hepatotoxins (e.g., D-galactosamine and 
actinomycin D) or with endotoxin to achieve an effect (Chen et al., 1994; Nagaki et al., 1994; 
Blank et al., 1997; Sugiyama et al., 1964). Endotoxin is a natural component of gram-negative 
bacteria found in the intestines and may actually contribute to shock syndromes. Although 
tissue damage from SE and lipopolysaccharide (LPS) may vary, acute shock caused by 
abnormally high levels of TNF-ǂ and other proinflammatory cytokines results in life-
threatening situations (Das, 2000; Miekthe et al, 1997; Sifka and Whitton, 2000). Thus, an 
animal model in which the SEB effects are magnified by sublethal concentrations of LPS 
provides an in vivo system useful for studying various facets of lethal shock. While each 
mouse model lacks some characteristics of the disease in humans, Krakauer et al. (2010) 
found that three different mouse models with different susceptibility to SEB could be used 
to study SEB intoxication.  
T-cell deficient mice or mice engineered to have specific cytokine deficiencies show that 
TNF-ǂ and T cells are both required for SE-induced lethality (Blank, et al. 1997). Transgenic 
mice expressing human TCR/MHC class II determinants solve some problems associated 
with mouse lymphoid cells binding SE and SAG-sensitive mice show a biphasic release of 
cytokines with early TNF-a release mediating lethal shock (Faulkner et al., 2005; 
Rajagopalan et al., 2002). These investigations point also to the spleen as a major source of 
TNF-a production during an acute (early) cytokine response. The studies support the idea 
that TSS is not simply due to cytokines released by T cells, but entails a series of events 
affecting major organs throughout the body. Recently, a humanized mouse in which T-cell 
immune deficient mice, SCID, were transfused with human hematopoietic fetal liver CD34+ 
cells that had previously been implanted with human fetal thymic and liver tissues 
developed long-term human innate and adaptive immune responses. When TSST-1 was 
injected into these mice, the mice responded immunologically in a manner similar to 
humans (Melkus et al., 2006) suggesting that this mouse model may overcome many of the 
problems associated with mouse models for SE intoxication.  
5.2 Rat 
Rats have been an excellent model to study TSS effects on the nervous system. Wang et al, 
(2004) showed activation of neuronal developmental genes after rats were given 
intraperitoneal injections of SEB. Activation appeared to occur through the tenth cranial 
nerve, the vagus, because severing this nerve prevented neuronal activation. These studies 
support the idea that brain-immune system communications play a role in TSS. Some 
sequalae of TSS relate to memory loss and confusion which would indicate involvement of 
the nervous system (Kusnocov and Goldfaith, 2005). 
5.3 Minature swine 
Because a major drawback for murine and rodent models in TSS is the lack of clinical 
symptoms that occur in humans, a porcine model has been developed in which 18-day-old 
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piglets are given a lethal dose of SEB intravenously (van Gessel et al., 2004). Intoxicated 
piglets develop vomiting, diarrhea, febrile temperature spikes, anorexia, and hypotension 
similar to the clinical course of disease observed in humans and may offer an in vivo model 
with more of the symptoms observed in human TSS. 
5.4 Rabbit 
McCormick et al. (2003) noted that rabbits, when given SAG by a continuous perfusion, 
developed pyrogenic symptoms similar to humans. Investigations showed that the lethal 
pathology was similar to that observed in human TSS, but with newer animal models and a 
greater understanding of mechanisms involved in TSS, rabbits are not a major animal model 
for TSS. 
5.5 Shrew 
Most of the small animal models used to study the effects of SE-intoxication do not display 
an emetic response (King, 1990). Hu et al. (2003) developed an emetic model with which to 
study SE-induced emesis. They reported that several SE serotypes, known to induce emesis 
in NHP, induced emesis in the house musk shrew (Suncus murinus). Concentrations 
required to induce an emetic response were approximately 0.4 μg per animal, but the dose 
varied with the SE serotype. Variations in SE toxicity among the serotypes were similar to 
those observed in NPHs and humans, making the shrew an excellent small animal model to 
study emesis induced by SEs.  
5.6 Nonhuman primate  
NHP exhibit a similar disease progression as that observed in humans and are susceptible 
when given SEB orally (Boles et al., 2003; Mattix et al., 1995; Ulrich et al., 1997). Because 
there are limitations in the number of NHP available for studies and because of the expense 
involved in NHP studies, they are usually reserved for preclinical investigations. While TSS 
manifestations in NHPs resemble those observed in humans, there are differences between 
the immune systems, which may become more evident as more is learned about the disease 
process.  
6. Therapy and prophylaxis 
Most therapeutic and prophylatic measures are concerned with TSS or systemic SE 
intoxication because food poisoning is usually self-limiting. Although identification of 
unusual food poisoning incidents should be monitored as a possible biothreat action, the 
disease itself should not be life-threatening, and recovery occurs without serious side effects. 
Because therapy for food poisoning is not a serious concern, this section will address the 
measures to treat disease pathogenesis resulting from systemic SE intoxication. 
6.1 Current therapeutic measures 
At the current time, intravenous human gamma globulins (IVIG) is the primary therapeutic 
to treat TSS. Because there are no specific drugs available for treatment, a primary goal of 
any therapeutic intervention is to maintain important body functions and physiological 
www.intechopen.com
 
Staphylococcal Enterotoxins, Stayphylococcal Enterotoxin B and Bioterrorism 
 
55 
homeostasis. Recommendations for treating TSS include first the removal of any foreign 
materials that might be contaminated with S aureus ( i.e., tampons or nasal packings) and 
draining sites of infection to prevent further bacterial growth. Treatment with anti-
microbials is also recommended if sepsis is involved. In severe cases, other therapeutic 
interventions that may minimize the risk of tissue damage and organ failure include fluids 
to prevent dehydration, dialysis if severe kidney problems occur, drugs to control blood 
pressure and cardiovascular function, anti-inflammatory agents, and possibly insulin, if 
needed. Supportive care should be aggressive and monitored carefully. Length of 
hospitalization may vary between 5 and 11 days (DeVries et al., 2011).   
6.2 Antibody therapy for SE intoxication 
As shown by studies in NHP, animals could be protected against SE intoxication using 
passive immunization with anti-SEB antibodies. The antibodies provided protection if given 
up to 4 hr after the NHPs had received 5 LD50sof aerosolized SEB (LeClaire et al., 2002). 
These studies showed that the antibodies were able to neutralize the toxin in vivo and 
provide protection after intoxication had occurred. Unfortunately, the antibody was a 
monoclonal antibody (Mab) created in a chicken, and the antibody itself may be antigenic 
and cause serum sickness. There are several anti-SEB Mab preparations that will not cause 
adverse reactions in humans. Because most Mabs are not developed using human cells, Mab 
development for human use will require “humanization of the Mab in order to eliminate the 
molecule’s antigenicity (Goldsmith and Signore, 2010). Investigations using immune 
lymphocytes to prepare Mabs may provide therapeutics without the expense of 
humanization. Additionally, developing small-domain antibody fragments such as camilid 
antibodies may also provide therapeutic agents that, because of their size, may not be 
antigenic in humans (Graef et al., 2011). Further studies are needed to identify antibody 
reagents that will be successful therapeutics, and whether the antibody reagents will need to 
be combined with pharmacologic agents to enhance their efficacy. 
6.3 Possible pharmacologic agents to treat SE intoxication 
Over the past 20 years, there have been numerous investigations showing efficacy of various 
pharmacologic agents that prevent or delay lethality when animals are treated after a SE 
challenge, and as yet none has advanced to human clinical trials (Krakauer, 2010). Human 
activated protein C (hAPC) was approved for patients in severe septic shock, and had been 
used to treat TSS (DeVries et al. 2011). On October 25, 2011, Eli Lilly withdrew Xigris (hAPC) 
because more in depth clinical trials indicated that drug did no better than a placebo in reducing 
mortality (http://www.medscape.com/viewarticle/752169). The complexity of TSS tends to 
discount development of a single drug capable of treating the disease . Because the disease 
affects the endothelial cell vasculature of multiple organ systems, including drugs that treat 
endothelial cell damage should also help to establish a therapeutic regimen for TSS.   
6.4 Vaccines 
To protect soldiers against SEB exposure, the U. S. Army developed a formalin-treated 
SEB toxoid that had some degree of success in protecting animals against a SEB challenge 
(Tseng et al., 1995). Due to the fact that formalin treatment did not always inactivate every 
toxin molecule, there was a move to develop vaccines without the need for formalin 
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inactivation. A vaccine developed by site-specific mutagenesis provided safer and more 
effective vaccines. The most effective vaccine (SEBvax) was designed with mutations in 
the MHC class II binding region so that the vaccine no longer was capable of cross-linking 
T cells to APCs (Ulrich et al., 1998). The military is no longer funding development of 
SEBvax. The vaccine is now being used to develop a trivalent subunit vaccine that 
includes mutated Tst-1 and SEA proteins as well. The combination vaccine should 
provide protection against SEB but also against SEs more commonly associated with TSS 
(http://www.regionalinnovation.org/success.cfm?story=32). 
7. Detection of SEs and SEB 
Since September 11, 2001, The U.S. and its allies have been concerned with detection of those 
agents that could be dispersed by aerosol (Kman and Bachman, 2011). There are several 
methods used for monitoring agents of bioterrorism and surveillance occurs through an 
umbrella of monitoring systems. A major component of surveillance, syndromic 
surveillance, results from the monitoring of clinical manifestations of certain illnesses to 
determine if there is a higher than normal number of cases. This is usually followed by 
laboratory surveillance in which certain markers and laboratory data indicate the presence 
of a bioterrorism agent. Another type of surveillance is environmental during which the 
environment is continually sampled for the presence of biological agents. In situations like 
SEB which is not generally monitored environmentally via the BioWatch Program, 
syndromic and laboratory surveillance becomes extremely important for monitoring 
bioterrorism attacks.  
SEs are stable proteins and therefore identification of the proteins using anti-SEB reagents 
should be possible in both the field and medical facilities. Available immunoassays are 
capable of identifying the protein in picogram amounts and can be used to monitor samples 
taken from the environment (Kahn et al. 2003; Sapsford et al., 2005). Because most humans 
have been exposed to SEs and have developed antibodies against them, the presence of anti-
SE antibodies is of little diagnostic value, but the detection of the toxin in body fluids or 
from nasal swabs (after an aerosol exposure), should provide a positive confirmation (Ulrich 
et al., 1997).  
In cases of infection with S. aureus, polymerase chain reaction (PCR) assays can determine 
the presence of the SE gene (Chiang et al., 2008; Rajkovic et al., 2006). Particularly in the case 
of a toxin that is known to be present in staphylococcal infections, surveillance and 
monitoring at the clinical level is imperative for differentiating between random outbreaks 
of the disease and a bioterrorist attack.  
8. Category B biothreat agent  
Although redefined after September 11, 2001, rogue nations have used bioterrorism for 
centuries as a method to harm their opponents (Bellamy and Freedman, 2001; Phillips, 2005). 
As described by CDC, bioterrorism agents are separated into three categories for 
preparedness purposes depending upon their ease of dissemination, and the ability to cause 
excessive morbidity and mortality (Rotz et al, 2002). Category A includes agents such as 
Variola major (smallpox) and Yersinia pestis (plague) that have been used as a weapon of 
mass destruction (WMD) (Henderson, 1999). As previously mentioned, Category B agents 
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are easy to disseminate and produce moderate morbidity and low mortality. Category B 
agents do not meet criteria for use as a WMD, but dispersal of a Category B agent could 
result in regional disruptions and hysteria.  
From all accounts, SEB meets the criteria for a Category B agent in that it is stable, easy to 
disseminate, and induces severe emesis and toxic shock. An aerosol of SEB in a crowded 
area could lead to an incapacitating disease in several hundred individuals. Although 
mortality would be low, the illness would create a serious public health impact by 
disrupting normal work days and cause havoc by increasing individual use of emergency 
rooms (Ulrich et al., 1997).  
Many bioterrorism agents such as SEB are found in nature, are easy to isolate and produce 
in mass quantities and are usually stable in adverse environmental conditions (Ahanotu, et 
al., 2006). Because the agent is a common inhabitant in the environment, monitoring the 
agent becomes more difficult. The fact that there are accidental cases of food poisoning and 
occasional cases of TSS annually also complicates identifying bioterrorism incidents using 
SEB. In the final analysis, although SEB may not be the most favored bioterrorism agent, 
there is always a possibility that it will be used in an attack and, therefore, mechanisms 
should be in place for decontamination and treatment.  
9. Summary 
SEs are produced primarily by S.aureus which is a common inhabitant in the environment 
worldwide. SEs are a major cause of food poisoning and toxic shock syndrome. In the 1960s, 
SEB was weaponized as an incapacitating agent, and now is listed as a Category B 
bioterrorism agent. When inhaled, the toxin causes severe respiratory damage and 
endothelial dysfunction, often resulting in acute respiratory distress and severe lung 
damage. As yet, there is no FDA-approved vaccine or therapeutic agents to prevent or treat 
SEB-intoxication and with its ease of dissemination, SEB remains a serious bioterrorism 
agent.   
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